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ABSTRACT
Cardiac angiosarcoma is a rare entity. The incidence through autopsy findings ranges between 0.001% and 0.03%. The 
disease usually presents with non-specific symptoms, although asymptomatic cases are frequent; therefore, diagnosis 
is unexpected and consequently delayed. The authors report the case of a middle-aged man with a recent onset cough 
and dyspnea. He sought medical care several times without receiving a definite diagnosis until a plain chest radiography 
was taken showing a mediastinal enlargement, which was the reason why he was hospitalized for clinical investigation. 
During the diagnostic workup, an echodopplercardiogram and a thoracic computed tomography were performed, 
showing a heterogeneous soft-tissue mass infiltrating the pericardium and the anterior atrial wall. Multiple and scattered 
pulmonary nodules were also present. A pulmonary nodule was biopsied, which revealed an angiosarcoma. The clinical 
features added to the radiological and histological findings permitted the diagnosis of right atrial angiosarcoma. The 
authors highlight the unexpected pattern in the presentation of cardiac tumors.
Keywords 
Hemangiosarcoma; Heart Neoplasms, Incidental Findings.
CASE REPORT
A 63-year-old male patient sought the medical 
facility complaining of recent productive cough and 
dyspnea. His past medical history included pulmonary 
tuberculosis, which was treated few years before, and 
smoking of 15 packs/year. He had sought medical 
care several times during the prior 2 months, but was 
always treated with symptomatic medication until a 
plain chest radiography was taken, which showed mild 
mediastinal enlargement and a bulging on the right 
atrium contour (Figure 1). This was the reason for the 
hospital admission and clinical investigation.
The initial physical examination revealed an 
afebrile patient, who presented normal hemodynamic 
parameters and no peripheral edema. Lung examination 
was normal, and cardiac auscultation revealed an 
ejection murmur. Raised jugular venous pressure and 
hepatomegaly were also observed. The remaining 
examination was normal and the initial laboratory 
workup was unremarkable.
The echodopplercardiogram showed pericardium 
thickening with mild effusion and a left ventricular 
ejection fraction of 60%. Thoracic computed 
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tomography (CT) showed a mass with soft tissue 
attenuation infiltrating the pericardium and the 
anterior wall of the right atrium (Figure 2) and multiple, 
bilateral, scattered, solid pulmonary nodules measuring 
up to 2.6 cm.
The magnetic resonance imaging (MRI) also 
showed a mass with heterogeneous distinction diffusely 
involving the pericardium, with compression/invasion 
of the right ventricle’s outflow tract, pulmonary artery 
and superior vena cava (Figures 3 and 4).
The pericardium was biopsied, but the histological 
examination did not reveal evidence of malignancy. A 
pulmonary nodule was subsequently biopsied, which 
showed a mesenchymal malignancy represented by 
sinusoidal vascular channels filled with red blood cells 
and lined with atypical endothelial cells (Figure 5A). 
The immunohistochemical profile showed positivity 
for CD31, CD34 (Figure 5B), while Desmin and 
S100 Protein were negative, rendering the diagnosis 
of angiosarcoma. Adding the radiological and clinical 
findings to the histological clues, the final diagnosis 
was metastatic angiosarcoma primary to the right 
atrium.
The pat ient received chemotherapy with 
doxorubicin 25 mg/m2 from day 1 to 3, and ifosfamide 
2000 mg/m2 from day 1 to 5 every 21 days. After 
two cycles, CT showed reduction in the size of the 
pulmonary nodules (from a maximum of 2.6 cm down 
to a maximum of 1.8 cm). Before the third cycle of 
chemotherapy, the patient was admitted to the the 
emergency department with a pulmonary infection. 
Despite intensive care, he developed refractory septic 
shock and died after 24 days.
DISCUSSION
Primary cardiac tumors are extremely rare. 
The incidence of these tumors in autopsy findings 
ranges from 0.001% to 0.03%.1 About 80% 
of the tumors are benign, and are represented 
Figure 1. Plain chest radiography showing a mediastinal 
enlargement with a bulging along the right atrium 
contour.
Figure 2. Axial computed tomography of the thorax. A, B - Soft tissue attenuating mass infiltrating the anterior wall 
of the right atrium (arrows); and in B, the pericardium (arrowhead).
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Figure 3. Cardiac MRI. A - T2 weighted image - (short axis double sequences) Heterogeneous mass with right atrium 
isosignal in the pericardial cavity (arrow) and a small area with slightly increased signal that can represent pericardial 
effusion (arrowhead); B - T2 weighted image - (after administration of gadolinium) Heterogeneous enhancement of 
the mass (arrow), consistent with tumor.
Figure 4. Cardiac MRI (T2 weighted images) showing heterogeneous hyperintense mass (arrows) in A, B, C - Left 
ventricle’s outlet, four-chamber view, and short-axis view, respectively.
Figure 5. Photomicrography of the biopsy of the pulmonary nodule. A - Sinusoidal vascular channels lined by 
atypical endothelial cells and areas of necrosis (arrow) (H&E, 400X); B - Cytoplasmic staining positive to vascular 
marker: CD34 (x100).
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mostly by atrial myxomas. The remaining cases are 
malignant neoplasias represented mostly by cardiac 
angiosarcomas with a specific type of differentiation, 
however undifferentiated pleomorphic sarcomas are 
more common.2-6
Angiosarcomas represent up to 30% of all cardiac 
malignancies.3 Although they can arise from any heart 
chamber, in the majority of cases they are found in the 
right atrium.7 Male and middle-aged patients, like the 
patient reported herein, are predominantly affected.3,8
The disease usually progresses without symptoms 
until the tumor burden compromises hemodynamic 
stability, and/or causes systemic derangement, 
or regional metastases arise.7 Symptoms may be 
nonspecific, such as a mild increase in temperature, 
weight loss, exhaustion, muscle pain, night sweats, 
and cough.8 Nonetheless, depending on the site of 
the tumor and its extension to the neighboring tissue 
infiltration, characteristic cardiac symptoms or signs 
will be present; such as angina, dyspnea, arrhythmias, 
stroke, and sudden cardiac arrest.7,9 Pericardial effusion 
and cardiac tamponade are frequent.10
Because of the non-specific presenting symptoms, 
and the unfamiliarity of most physicians with this entity, 
the diagnosis is overlooked and consequently often 
delayed.11 Besides the diagnostic delay, the aggressive 
behavior characterized by the early spreading of the 
tumor and rapid local infiltration contribute to the poor 
prognosis.12 Most patients die within a few months 
after diagnosis.13
Some patients are incidentally diagnosed when 
submitted to thoracic imaging for other purpose. 
Non-invasive cardiac imaging greatly contributes to 
the radiologic evaluation of these tumors.
Intracardiac thrombus or vegetation constitute 
the main differential diagnoses; thus, the first step 
during diagnostic evaluation is ruling out these other 
diagnostic possibilities,7 usually by echocardiography.14 
In this setting, transesophageal echocardiogram shows 
97% of sensitivity in diagnosing cardiac masses.15 In 
cases of an inconclusive cardiac tumor diagnosis by 
the former examination, CT or magnetic resonance 
imaging (MRI) can be utilized.7
MRI allows better overall soft-tissue characterization 
and is more versatile than the CT when it can provide 
some functional information, such as flow direction 
and flow velocity in large vessels.16 However, CT is more 
readily available in most centers, been then a modality 
of choice for evaluating abnormalities intrinsic to the 
myocardium.
Optimal images are important when preceding 
surgical resections, but in the present case performing 
both modalities in parallel did not alter the clinical 
reasoning.
There are two main morphologic types described 
in angiosarcoma. The first is a well-defined mass 
protruding into one of the cardiac chambers, usually 
the right atrium.17,18 CT often shows a low-attenuating 
right atrium mass, which may be irregular or nodular. 
The contrast medium enhancement is heterogeneous.16 
The second morphologic type is a diffusely infiltrative 
mass extending along the pericardium that may appear 
on CT as pericardial effusion or thickening.16,18
Because of the tumor propensity to bleeding 
and the presence of necrosis, heterogeneous signal 
intensity on CT and MRI is typical. On T1-weighted fast 
spin-echo (FSE) sequences, tumors are typically low-
signal, and T2-weighted FSE images typically show an 
increased signal. Areas of increased signal intensity on 
T1-weighted images (focal or peripheral) are thought 
to represent blood products and because of their high 
vascularity, strong signal enhancement is seen after 
gadolinium injection.18,19
18F-fluorodeoxyglucose-positron emission 
tomography/computed tomography (FDG PET/CT) is 
another tool that can be helpful in the determination 
of the tumor’s malignant potential as well as tumoral 
staging.20 However, histological diagnosis still remains 
the diagnostic gold standard.21
Unfortunately, at the time of diagnosis, metastases 
are frequently present and are mostly disseminated 
to the lungs, although lymph nodes, bone, adrenal 
glands, liver, and spleen may also be involved.22
An interdisciplinary approach is crucial in the 
management of cardiac tumors. Considering the rarity 
of this malignancy, there is no recommended standard 
therapy and evidence is based on single case reports 
and retrospective series.
Surgical resection plays an important role, not 
only with a curative goal, but also to restore normal 
hemodynamics. Complete resection is the treatment 
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of choice, although many patients show progression 
of the disease even after resection.1
Adjuvant chemotherapy and radiotherapy have 
been described in case series, but no randomized trials 
have been conducted. Therefore, the benefit of these 
modalities in reducing local and distant recurrences 
after complete resection is uncertain.
Llombart-Cussac et al.23 reported a series with 
15 patients with localized cardiac sarcomas (6 of 
whom had angiosarcomas) who were treated with 
adjuvant doxorubicin-containing regimen within 6 
weeks after a complete resection. The overall median 
time to recurrence was 10 months. For those patients 
with angiosarcoma, this median time was 3 months. 
Median survival time for angiosarcoma was 7 months.23 
However, combined modality and adjuvant therapy can 
provide long-term disease control.24-26
Heart transplantation has been considered as a 
final treatment option in individual cases, especially in 
young patients with no other treatment option,27 but 
the reported outcomes are discouraging.28
In the metastatic scenario, chemotherapy may 
provide symptom relief, improve quality of life, and 
increase survival time. Prospective clinical trials on 
advanced soft tissue sarcoma researching clinical 
benefit with doxorubicin-based chemotherapy did not 
individualize outcomes of patients with angiosarcoma. 
However, many reports suggest a substantial rate of 
response with doxorrubin, doxorubicin plus ifosfamide, 
vincristine and taxanes.29-31 Recent phase II trials, with 
target therapies sorafenib and bevacizumab in the 
treatment of advanced angiosarcoma, have yielded 
promising results on the efficacy of these agents.32
In the present case, diagnosis was not suspected 
on clinical grounds. The suspicion was raised after plain 
thoracic radiography and henceforth was enlightened 
with other imaging techniques. Angiosarcoma was 
confirmed with the immunohistochemical panel of a 
pulmonary nodule biopsy. Cardiac tumors, although 
rare, are somewhat easily diagnosed with the additional 
of imaging methods. Obtaining histological samples 
may be troublesome. When metastatic disease is the 
presenting form, pathological documentation may be 
more easily accessed. Awareness of the entity and the 
knowledge of its clinical features are the cornerstone 
to decreasing the delay in diagnosis.
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